• All Courts
  • Federal Courts
  • Bankruptcies
  • PTAB
  • ITC
Track Search
Export
Download All
Active Filters
Displaying 384-398 of 977 results

1003 Exhibit: Ex 1003 Prosecution history excerpts for US Patent No 8,114,833

Document IPR2020-01252, No. 1003 Exhibit - Ex 1003 Prosecution history excerpts for US Patent No 8,114,833 (P.T.A.B. Jul. 22, 2020)

cite Cite Document
Analyze

1024 Exhibit: Ex 1024 Akers, Formulation Development of Protein Dosage Forms P...

Document IPR2020-01252, No. 1024 Exhibit - Ex 1024 Akers, Formulation Development of Protein Dosage Forms Part 1 (P.T.A.B. Jul. 22, 2020)

cite Cite Document
Analyze

1023 Exhibit: Ex 1023 Handbook of Pharmaceutical Excipients 3d ed 2000 Part 4

Document IPR2020-01252, No. 1023-5 Exhibit - Ex 1023 Handbook of Pharmaceutical Excipients 3d ed 2000 Part 4 (P.T.A.B. Jul. 22, 2020)

cite Cite Document
Analyze

1024 Exhibit: Ex 1024 Akers, Formulation Development of Protein Dosage Forms P...

Document IPR2020-01252, No. 1024-2 Exhibit - Ex 1024 Akers, Formulation Development of Protein Dosage Forms Part 2 (P.T.A.B. Jul. 22, 2020)

cite Cite Document
Analyze

1030 Exhibit: Ex 1030 US Patent No 5,514,097

Document IPR2020-01252, No. 1030 Exhibit - Ex 1030 US Patent No 5,514,097 (P.T.A.B. Jul. 22, 2020)

cite Cite Document
Analyze

1029 Exhibit: Ex 1029 FDA Guidance for Industry Chemistry Manufacturing and Co...

Document IPR2020-01252, No. 1029 Exhibit - Ex 1029 FDA Guidance for Industry Chemistry Manufacturing and Controls 2003 (P.T.A.B. Jul. 22, 2020)

cite Cite Document
Analyze

1002 Exhibit: Ex 1002 EXPERT DECLARATION OF LAIRD FORREST, PhD

Document IPR2020-01252, No. 1002 Exhibit - Ex 1002 EXPERT DECLARATION OF LAIRD FORREST, PhD (P.T.A.B. Jul. 22, 2020)

cite Cite Document
Analyze

1004 Exhibit: Ex 1004 International Publication NO WO 03002136

Document IPR2020-01252, No. 1004-2 Exhibit - Ex 1004 International Publication NO WO 03002136 (P.T.A.B. Jul. 22, 2020)

cite Cite Document
Analyze

1023 Exhibit: Ex 1023 Handbook of Pharmaceutical Excipients 3d ed 2000 Part 3

Document IPR2020-01252, No. 1023-2 Exhibit - Ex 1023 Handbook of Pharmaceutical Excipients 3d ed 2000 Part 3 (P.T.A.B. Jul. 22, 2020)

cite Cite Document
Analyze

1012 Exhibit: Ex 1012 MODERN PHARMACEUTICS Part 1

Document IPR2020-01252, No. 1012-3 Exhibit - Ex 1012 MODERN PHARMACEUTICS Part 1 (P.T.A.B. Jul. 22, 2020)

cite Cite Document
Analyze

1012 Exhibit: Ex 1012 MODERN PHARMACEUTICS Part 2

Document IPR2020-01252, No. 1012 Exhibit - Ex 1012 MODERN PHARMACEUTICS Part 2 (P.T.A.B. Jul. 22, 2020)

cite Cite Document
Analyze

1012 Exhibit: Ex 1012 MODERN PHARMACEUTICS Part 3

Document IPR2020-01252, No. 1012-2 Exhibit - Ex 1012 MODERN PHARMACEUTICS Part 3 (P.T.A.B. Jul. 22, 2020)

cite Cite Document
Analyze

1023 Exhibit: Ex 1023 Handbook of Pharmaceutical Excipients 3d ed 2000 Part 2

Document IPR2020-01252, No. 1023-4 Exhibit - Ex 1023 Handbook of Pharmaceutical Excipients 3d ed 2000 Part 2 (P.T.A.B. Jul. 22, 2020)

cite Cite Document
Analyze

1011 Exhibit: Ex 1011 J Jacobs, Factors Influencing Drug

Document IPR2020-01252, No. 1011 Exhibit - Ex 1011 J Jacobs, Factors Influencing Drug (P.T.A.B. Jul. 22, 2020)

cite Cite Document
Analyze

1007 Exhibit: Ex 1007 EP 0 923 950

Document IPR2020-01252, No. 1007 Exhibit - Ex 1007 EP 0 923 950 (P.T.A.B. Jul. 22, 2020)

cite Cite Document
Analyze
<< 1 2 3 4 5 ... 26 27 28 29 30 ... >>